SUMMARY Cryoproteins were isolated from the serum of 5 patients with essential cryoglobulinaemia, 5 patients with rheumatoid arthritis, and 2 patients with Sj0gren's syndrome. These cryoprecipitates contained IgG, IgM, and IgA as well as complement proteins Clq, C4, C3, and factor B. The cryoprecipitates were analysed further for content of antibody and antigen, and were tested for their ability to activate complement. In the cryoprecipitates of 2 patients with Sj0gren's syndrome, nuclear antigen and antinuclear antibody characteristic of an immunological specificity found in Sj0gren's syndrome were shown. The cryoprecipitates of 6 other patients contained rheumatoid factor and antibody to a lymphocyte nuclear antigen.
Although proteins that precipitate from serum in the cold were first observed in multiple myeloma (Wintrobe and Buell, 1933) , cryoproteins have since been detected in the sera of patients with many other diseases (Franklin, 1971; Brouet et al., 1974) . Cryoproteins of patients with autoimmune diseases such as systemic lupus erythematosus (SLE) have been shown to contain antigen-antibody complexes and to be rich in antibodies to nuclear ribonucleoprotein, single-stranded DNA (ss-DNA), and double stranded DNA (ds-DNA) (Winfield et al., 1975) .
Cryoproteins have also been detected in patients with viral hepatitis and infectious mononucleosis (Kaplan, 1968; Kohler et al., 1974) . Hepatitis B antigen and antibody have been found in the proteins of some patients with extrahepatic manifestations of acute viral hepatitis such as arthritis and nephritis (Kohler et al., 1974; Wands et al., 1975) . These data suggest that the phenomenon of serum cryoprecipitation may be related to the presence of immune complexes in the serum. An association has been found between the presence of cryoproteins and decreased serum levels of complement (Hanauer and Christian, 1967; Stastny and Ziff, 1969) . Several different studies suggest that complement activation occurs in patients with cryoproteinaemia. Complement proteins of the classical pathway, Clq and C4, have been detected in the cryoprecipitates of patients with SLE (Hanauer and Christian, 1967) , and C4, C3, and C5 in the cryoprecipitates of patients with hepatitis (Wands et al., 1975) . Cryoprecipitates have also been shown to activate complement by in vitro assays (Wands et al., 1975; Muller et al., 1976) . Stastny and Ziff (1969) reported that the isolated cryoprecipitates of a patient with SLE and of a patient with rheumatoid arthritis (RA) consumed complement proteins in vitro. Tesar et al. (1973) have described activation of the alternative complement pathway by mixed cryoglobulins from the synovial fluid and sera of patients with RA.
We studied the cryoprecipitates of patients with essential monoclonal and mixed cryoglobulinaemia, as well as cryoproteinaemia associated with RA and Sjogren's syndrome. We also studied the ability of these cryoprecipitates to activate complement by the classical or alternative complement pathways. We found that the cryoprecipitates of patients with Sj0gren's syndrome contained nuclear antigen and antinuclear antibody characteristic of an immunological specificity found in Sj0gren's syndrome (Alspaugh and Tan, 1975) . A number of cryoprecipitates contained rheumatoid factor and an antibody to a lymphocyte antigen which has recently been described . All 12 cryoprecipitates activated the classical complement pathway in in vitro assays, and 9 also activated the alternative pathway independently.
Materials and methods

PATIENTS
We studied 5 patients with essential cryoglobulinaemia, 5 patients with cryoglobulinaemia associated with RA, and 2 patients with Sj0gren's syndrome. 4 were male and 8 were female, ages ranging from 48 to 72 years. Clinical data are summarized in Table 1 . 5 patients (Cases 3-7) had essential cryoglobulinaemia and purpura of the type described by Meltzer et al. (1966) . 3 (Cases 3, 4, 5) had renal disease shown by microscopical haematuria and 1-2 g urinary protein/24 hours. Percutaneous renal biopsy of Case 3 showed proliferative glomerulonephritis.
Five patients with RA (Cases 8-12) met the criteria of the American Rheumatism Association for classical or definite RA (Ropes et al., 1958 ). An extract of cellular antigens from a human lymphoid cell line (Wil2) was used as a source of SS-A, SS-B, and RA precipitin antigens (Alspaugh and Tan, 1975) . Antibodies to ss-DNA and ds-DNA were detected by methods described by Picazo and Tan (1975) . Antibodies to Sm antigen and nuclear ribonucleoprotein, two acidic nuclear proteins, were identified by the Ouchterlony technique using reference prototype sera from SLE patients and patients with mixed connective tissue disease (Northway and Tan, 1972) . Antibody titre was determined by the passive haemagglutination assay (Tan and Peebles, 1976) . Antiglobulin antibodies were determined by latex agglutination (ffyland Div., Travenol Laboratories).
COMPLEMENT ASSAYS Fresh sera from 3 patients (Cases 1, 5, 6) were immediately tested for total haemolytic complement (CH50) activity by the method of Mayer (1961) . Serum levels of Clq, C4, factor B, and C3 were also measured by single radial immunodiffusion with monospecific antisera to these proteins (Mancini et al., 1965 ). (Gotze and Muller-Eberhard, 1972) . Fresh normal human serum in EGTA was the source of C5b-9 complexes if this had been generated during alternative pathway activation. Briefly, GSHE (5 x 107 cells) were incubated with 50 ,ul cryoprecipitate and 50 ,d fresh normal serum in the presence of EGTA (10 mmol/l) and MgCI2 (0 5 mmol/l). These conditions block classical complement pathway activation but permit activation of the alternative complement pathway. After incubation in a water bath at 37°C for 60 minutes, 2 ml cold saline was added. After mixing and centrifugation, the amount of free haemoglobin was determined spectrophotometrically at 412 nm. Normal serum activated by inulin in the presence of EGTA and Mg+ + was used as the standard for 100% lysis.
The second method was factor B conversion into split products. 5 pd cryoprecipitate (0-5 mg/ml in PBS) and 20 ,ul fresh normal human serum in the presence of EGTA (10 mmol/l) and MgCl2 (0 5 mmol/l) were reacted at 37°C for 30 minutes. The mixture was then electrophoresed on a microscope slide coated with 1 5 % agarose using veronal buffer pH 8 -6 (ionic strength 0 05) and EDTA (0 02 mol/l). The slide was developed with monopsecific antisera to factor B. Conversion of factor B indicating alternative complement pathway activation was detected by the appearance of split products with alpha and gamma mobility .
The isolated cryoprecipitates were dissolved in 0-06 M glycine-HCI buffer (pH 3 2). After solubilization, a 0-25 ml sample (4 mg/mil) was layered on to a 4 5 ml linear 10-40 % sucrose gradient made in the same buffer. The gradients were formed by using a Buchler automatic density gradient maker (Buchler Instruments Division, Nuclear Chicago, Fort Lee, N.J. Clq, C4, C3, and factor B of the alternative pathway were detected in most of the isolated cryoprecipitates (Table 1 ). The C3 which was detected in the cryoprecipitates had the electrophoretic mobility of split products C3c and C3d by counterimmunoelectrophoresis (Arroyave and Tan, 1976 . These antibodies were tested by immunodiffusion and were detected in the sera of 11 patients and in the cryoprecipitates of 6 patients.
The relative difference in titre of RA precipitin between the serum and cryoprecipitates was found by determining the titre of the samples to an endpoint against a standard WiJ2 antigen extract using the Ouchterlony technique. There was 32-to 80-fold enrichment of these antibodies in cryoprecipitates compared to sera.
Indirect immunofluorescence was used to detect ANA in the sera of the 12 patients. The sera of 7 patients were positive for ANA. The sera of both patients with Sj0gren's syndrome produced a speckled nuclear pattern. In order to detect ANA in the cryoprecipitates, acid dissociated SDG proteins (see 'Methods') were tested for ANA by indirect immunofluorescence. Fig. 1 We decided to analyse the ANA in the cryoprecipitates of the 2 patients with Sj0gren's syndrome for the immunological specificities SS-A and SS-B, previously found in the sera of such patients (Alspaugh and Tan, 1975) . However, the concentration of antibody in the SDG fractions was either insufficient or incapable of forming precipitin reaction with tissue extracts in immunodiffusion techniques, so an immunofluorescent blocking experiment was used (see 'Methods') ( Table 3 ). The SDG fractions of the cryoprecipitates of both patients with Sj0gren's syndrome were reacted first with the tissue substrate followed by the FITClabelled reagent. Only the 7S fractions blocked the speckled nuclear pattern, indicating the presence of SS-B antibodies in these fractions. The antibodies were enriched 12-and 32-fold in the cryoprecipitates compared to sera. In order to determine if antigen was present in the cryoprecipitates of both Sj0gren's patients, the 7S fractions were absorbed with other fractions of the gradient. The results (Fig. 1) for Case 1 show that only the 19S and heavier fractions were able to absorb the speckled nuclear immunofluorescent pattern of the 7S fraction, suggesting the presence of antigen in the heavier fractions of the gradient.
No antibodies to SS-A, another ANA specificity characteristic of Sj0gren's syndrome (Alspaugh and Tan, 1975) , were detected in the sera or cryoprecipitates. Antibodies to ss-DNA, ds-DNA, nuclear ribonucleoprotein, and Sm antigen were not detected in the solubilized cryoprecipitates or SDG fractions of any of these patients.
SERUM COMPLEMENT STUDIES
The serum levels of CH50 and Clq, C4, and factor B are given in Table 4 . 7 patients had CH50 levels below normal, 6 patients had decreased levels of Clq and C4, and 2 had levels of factor B which were lower than normal.
The ability of the isolated cryoprecipitates to activate the classical complement pathway was determined by the per cent consumption of haemolytic C4 when the cryoprecipitates were incubated with fresh normal human serum. Activation of the alternative complement pathway by isolated cryoprecipitate was determined by lysis of GSHE cells and immunoelectrophoretic conversion of factor B when the cryoprecipitates were incubated with fresh normal human serum under conditions where Cl and C4 activation was inhibited (see 'Methods') ( Table 5 ). The cryoprecipitates of all but one patient activated the classical complement pathway. Consumption of C4 ranged from 8 to 66%. 8 of the 12 cryoprecipitates produced more than 10% lysis of Table 4 Serum complement levels ofpatients with cryoglobulinaemia GHSE cells, which in our laboratory is significant for activation of the alternative complement pathway. The per cent lysis produced by the cryoprecipitates ranged from 18 to 48%. In addition, the same 9 isolated cryoprecipitates produced conversion of factor B into split products of alpha and gamma mobilities. Heating the cryoprecipitates to 56°C for 30 minutes before testing caused no change in the per cent lysis of GHSE or conversion of factor B.
Discussion
The presence of antigen-antibody complexes in the cryoprecipitates of patients with immunological diseases has been demonstrated (Winfield et al., 1975; Wands et al., 1975) . Winfield et al. described an enrichment of antibodies to nuclear ribonucleoprotein, ss-DNA, and ds-DNA, as well as DNA antigen in the cryoprecipitates of SLE patients. Hepatitis B antigen and antibody have been detected in the cryoprecipitates of patients with extrahepatic manifestations of viral hepatitis, such as nephritis and arthritis (Kohler et al., 1974; Wands et al., 1975) . In each of these studies the immune complexes shown in the cryoprecipitates appeared to be of specificities which were characteristic of the disease in which they were found.
Our patients had cryoglobulinaemia associated with the various clinical features of Sj0gren's syndrome, rheumatoid arthritis, and idiopathic purpura.
In the majority mixed cryoglobulins were shown, in agreement with previous reports that this type of cryoglobulin is more frequent in autoimmune disorders. In 7 of our 12 patients, autoantibodies could be detected in the cryoproteins. 2 patients with Sj0gren's syndrome had ANA of the SS-B specificity, a type which has been found in the sera of approximately one-half of patients with Sj0gren's syndrome and to a lesser extent in other autoimmune diseases (Kurata and Tan, 1976) . ANA activity could only be detected in cryoproteins after procedures which dissociated and separated antigen-antibody complexes. In addition, the homologous SS-B antigen was detected in the dissociated cryoproteins.
In 5 patients (3 with essential cryoproteinaemia, 2 with RA) conventional ANA was not detected in the cryoproteins although 2 had ANA in their sera. In 5 patients the cryoproteins were rich in rheumatoid arthritis precipitin. This had been described as a precipitating antibody to a lymphocyte-associated antigen and is devoid of rheumatoid factor activity . These 5 patients also had 19S rheumatoid factor in their cryoproteins.
The detection ofa wide variety ofimmune reactants and complement in cryoproteins adds to the evidence that cryoprecipitation from serum may be a manifestation of pre-existing immune complexes in the circulation. In the 2 patients with Sj0gren's syndrome the immune complexes may have consisted of SS-B antigen and antibody, since they were both present in the cryoproteins. In 5 patients the immune complexes may have consisted of RA precipitin and its homologous lymphocyte antigen. We were unable to show the presence of the latter antigen in the cryoproteins, perhaps because of a lack of sensitivity of our assay system. Finally, other serum proteins such as rheumatoid factor and complement may be associated with cryoprecipitation, either by making a primary contribution to the property of cryoprecipitability or secondarily by their association with antigen-antibody complexes. It has been suggested that Clq plays a major role in cryoprecipitation, since IgG and Clq isolated from cryoglobulins precipitated in the cold when mixed together (Stastny and Ziff, 1969) . No complement proteins were detected in the cryoprecipitates of 3 patients. These were the patients with no Clq in the cryoprecipitates. It is possible that complement proteins were present in the cryoprecipitates but at levels below the sensitivity of the detection system.
The pattern of interaction of cryoglobulins with complement resembles the pattern of complement activation of mixed cryoglobulin, described by others in that they activated preferentially the early complement components. The classical pathway was activated by the cryoprecipitates of all 12 patients, and it has been shown by other workers that cryoprecipitates, like aggregates of human immunoglobulins, will activate complement (Rother et al., 1972; Muller et al., 1976) . Of great interest was the fact that 9 of the 12 cryoprecipitates activated the alternative pathway. Since the initial reactions of classical pathway were blocked in our in vitro assays by the presence of EGTA, activation of the alternative pathway probably occurred independently. Similar activation of the alternative pathway was shown by Rother et al. (1972) who incubated different cryoglobulins in C4-deficient guinea pig sera and found a decrease in the C3-9 haemolytic activity. The loss of C3-9 under these conditions was considered evidence for direct activation of the alternative pathway by cryoglobulins. It is important to consider that the alternative pathway was activated via the C3b feedback cycle (Medicus et al., 1976) . However, the only antigenic C3 detected in our solubilized cryoprecipitates had the electrophoretic mobility of C3c/C3d. These proteins, unlike C3b, are not known to participate in the feedback cycle of complement activation via factor B.
The monoclonal IgG cryoprecipitates of 2 patients (Cases 6, 7) activated the alternative pathway, as did that of a patient with a similar type monoclonal cryoprecipitate reported by Muller et al. (1976) . Thompson (1972) has shown that immunoglobulin fractions rich in IgG3 isolated from patients with chronic hypocomplementaemic glomerulonephritis activated the alternative pathway. Others have also reported that certain specific subclasses of IgG myeloma may activate the alternative pathway (Spiegelberg and Gotze, 1972; Frank et al., 1976) .
The demonstration of the immune complex nature of most mixed cryoglobulins suggests that such complexes may be responsible for acute vasculitis in vivo. Clinically there seemed to be some correlation between the presence of cutaneous vasculitis and cryoprecipitates which activated the complement system. 7 patients with skin biopsies compatible with vasculitis had cryoprecipitates which activated both the classical and alternative pathways. Of the 2 patients without cutaneous vasculitis who had such cryoprecipitates, one (Case 2) had myocardiopathy and one (Case 9) had peripheral neuropathy, conditions which might have been associated with localized vasculitis. All 9 patients had proteins of the classical and alternative complement pathway in their cryoprecipitates. When immunofluorescent studies were performed in 2 patients the fresh vasculitic skin lesions showed deposits of two alternative pathway proteins, properdin and factor B, in dermal vessels. In the skin lesion of Case 1 no Clq could be detected but this was present in the other patient, Case 5. Immunopathological studies of the skin were not available for the other patients. 
